NCT03356392 German Stroke Registry - Endovascular Treatment
| NCT ID | NCT03356392 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2015-06 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2015-06 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent, prospective, multicentre, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of acute ischemic stroke * Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after stroke onset * Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms * Age \>18 years * Ethic approval in process Exclusion Criteria: none
Contact & Investigator
Martin Dichgans, Prof. Dr. med.
PRINCIPAL INVESTIGATOR
LMU, Munich, Germany
Frequently Asked Questions
Who can join the NCT03356392 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03356392 currently recruiting?
Yes, NCT03356392 is actively recruiting participants. Contact the research team at m.schell@uke.de for enrollment information.
Where is the NCT03356392 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT03356392 clinical trial?
NCT03356392 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Martin Dichgans, Prof. Dr. med. at LMU, Munich, Germany. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.